Literature DB >> 3947486

Diagnostic and surgical management of patients with aneurysms of the thoracic aorta with various causes. Echocardiography and contrast enhanced computed tomography in prophylactic replacement of the ascending aorta.

L Bruno, M Prandi, P Colombi, L La Vecchia.   

Abstract

Sixty eight patients with aneurysms of the thoracic aorta were studied. Forty one had aortic dissection, 24 had dilatation only, and three had transverse aortic rupture. Sixteen had Marfan's syndrome; 17 had hypertension; and in eight there were other causal factors. In 17 the cause of the aneurysm was unknown. Histological examination did not help to establish the cause of aneurysm. Echocardiography failed to detect dissection of the ascending aorta in four (21%) out of 19 cases studied. The mortality rate in the whole series was 26%. Early (operative and hospital) and late deaths occurred in 20% and 6% of patients respectively. The early mortality rate was 40% in the 24 emergency cases of dissection of the ascending aorta, 9% in patients operated on for dilatation of the ascending and transverse aorta without dissection, and 8% in patients with chronic dissection of the ascending aorta who had elective operation. Early and late mortality rates were no higher in patients with Marfan's disease than in any of the other groups. It is suggested that contrast enhanced computer tomography should be performed in all patients with pronounced aortic root dilatation and in patients with Marfan's disease with symptoms which suggest dissection, even if they have only slight aortic root dilatation. Preventive replacement of the ascending aorta should be considered in more patients to reduce the number of emergency operations, in which the mortality rate is high. There is no definite limit of aortic root dilatation above which preventive replacement of the ascending aorta should be routinely considered.

Entities:  

Mesh:

Year:  1986        PMID: 3947486      PMCID: PMC1232072          DOI: 10.1136/hrt.55.1.81

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  22 in total

1.  Dissection of the thoracic aorta. Medical or surgical therapy?

Authors:  J E Dalen; J S Alpert; L H Cohn; H Black; J J Collins
Journal:  Am J Cardiol       Date:  1974-12       Impact factor: 2.778

2.  Ocular manifestations in the Marfan syndrome and homocystinuria.

Authors:  H E Cross; A D Jensen
Journal:  Am J Ophthalmol       Date:  1973-03       Impact factor: 5.258

3.  Medical vs surgical treatment of acute dissecting aneurysms.

Authors:  S Attar; R Fardin; R Ayella; J S McLaughlin
Journal:  Arch Surg       Date:  1971-11

4.  Cystic medial necrosis of the ascending aorta in relation to age and hypertension.

Authors:  R G Carlson; C W Lillehei; J E Edwards
Journal:  Am J Cardiol       Date:  1970-04       Impact factor: 2.778

5.  Management of cardiovascular complications in Marfan syndrome.

Authors:  R M Donaldson; R W Emanuel; E G Olsen; D N Ross
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

6.  Realistic expectations of surgical treatment of aortic dissections: the Stanford experience.

Authors:  D C Miller; E B Stinson; N E Shumway
Journal:  World J Surg       Date:  1980-09       Impact factor: 3.352

7.  Progress in treatment of aneurysms of the aortic arch.

Authors:  M A Ergin; R B Griepp
Journal:  World J Surg       Date:  1980-09       Impact factor: 3.352

8.  Therapy of dissecting aneurysms.

Authors:  W G Austen; M J Buckley; J McFarland; R W DeSanctis; C A Sanders
Journal:  Arch Surg       Date:  1967-11

9.  Dissecting aneurysm of aorta complicating aortic valvular stenosis.

Authors:  T Fukuda; S M Tadavarthy; J E Edwards
Journal:  Circulation       Date:  1976-01       Impact factor: 29.690

10.  Cardiac, skeletal, and ocular abnormalities in patients with Marfan's syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis.

Authors:  L Bruno; S Tredici; M Mangiavacchi; V Colombo; G F Mazzotta; C R Sirtori
Journal:  Br Heart J       Date:  1984-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.